Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/218796
Title: Heterogeneous IL-9 Production by Circulating Skin-Tropic and Extracutaneous Memory T Cells in Atopic Dermatitis Patients
Author: García-Jiménez, Irene
Sans-de San Nicolás, Lídia
Curto-Barredo, Laia
Bertolín-Colilla, Marta
Sensada-López, Eloi
Figueras Nart, Ignasi
Bonfill-Ortí, Montserrat
Guilabert-Vidal, Antonio
Ryzhkova, Anna
Ferran, Marta
Damiani, Giovanni
Czarnowicki, Tali
Pujol Vallverdú, Ramón M.
Santamaria Babí, Luis F.
Keywords: Cèl·lules T
Dermatitis atòpica
Interleucines
T cells
Atopic dermatitis
Interleukins
Issue Date: 6-Aug-2024
Publisher: MDPI
Abstract: Interleukin (IL)-9 is present in atopic dermatitis (AD) lesions and is considered to be mainly produced by skin-homing T cells expressing the cutaneous lymphocyte-associated antigen (CLA). However, its induction by AD-associated triggers remains unexplored. Circulating skin-tropic CLA+ and extracutaneous/systemic CLA− memory T cells cocultured with autologous lesional epidermal cells from AD patients were activated with house dust mite (HDM) and staphylococcal enterotoxin B (SEB). Levels of AD-related mediators in response to both stimuli were measured in supernatants, and the cytokine response was associated with different clinical characteristics. Both HDM and SEB triggered heterogeneous IL-9 production by CLA+ and CLA− T cells in a clinically homogenous group of AD patients, which enabled patient stratification into IL-9 producers and non-producers, with the former group exhibiting heightened HDM-specific and total IgE levels. Upon allergen exposure, IL-9 production depended on the contribution of epidermal cells and class II-mediated presentation; it was the greatest cytokine produced and correlated with HDM-specific IgE levels, whereas SEB mildly induced its release. This study demonstrates that both skin-tropic and extracutaneous memory T cells produce IL-9 and suggests that the degree of allergen sensitization reflects the varied IL-9 responses in vitro, which may allow for patient stratification in a clinically homogenous population.
Note: Reproducció del document publicat a: https://doi.org/10.3390/ijms25168569
It is part of: International Journal of Molecular Sciences, 2024, vol. 25, num.16, p. 1-14
URI: https://hdl.handle.net/2445/218796
Related resource: https://doi.org/10.3390/ijms25168569
ISSN: 1661-6596
Appears in Collections:Articles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia)

Files in This Item:
File Description SizeFormat 
880723.pdf2.46 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons